109 related articles for article (PubMed ID: 15094651)
1. Pelizaeus-Merzbacher disease: diffusion MR imaging and proton MR spectroscopy findings.
Sener RN
J Neuroradiol; 2004 Mar; 31(2):138-41. PubMed ID: 15094651
[TBL] [Abstract][Full Text] [Related]
2. Proton MR spectroscopy in connatal Pelizaeus-Merzbacher disease.
Spalice A; Popolizio T; Parisi P; Scarabino T; Iannetti P
Pediatr Radiol; 2000 Mar; 30(3):171-5. PubMed ID: 10755756
[TBL] [Abstract][Full Text] [Related]
3. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
4. Classification of childhood white matter disorders using proton MR spectroscopic imaging.
Bizzi A; Castelli G; Bugiani M; Barker PB; Herskovits EH; Danesi U; Erbetta A; Moroni I; Farina L; Uziel G
AJNR Am J Neuroradiol; 2008 Aug; 29(7):1270-5. PubMed ID: 18483189
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
[TBL] [Abstract][Full Text] [Related]
6. [Clinical symptoms and characteristic MR spectroscopic findings in Pelizaeus-Merzbacher disease].
Kurata K; Itoh M; Uchiyama A; Kurano N; Kumada S; Komine M; Tanuma N; Tomita S; Matsui R
No To Hattatsu; 2000 Nov; 32(6):503-8. PubMed ID: 11144164
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis.
Balasubramanya KS; Kovoor JM; Jayakumar PN; Ravishankar S; Kamble RB; Panicker J; Nagaraja D
Neuroradiology; 2007 Feb; 49(2):177-83. PubMed ID: 17131116
[TBL] [Abstract][Full Text] [Related]
8. Congenital muscular dystrophy with merosin deficiency: 1H MR spectroscopy and diffusion-weighted MR imaging.
Leite CC; Reed UC; Otaduy MC; Lacerda MT; Costa MO; Ferreira LG; Carvalho MS; Resende MB; Marie SK; Cerri GG
Radiology; 2005 Apr; 235(1):190-6. PubMed ID: 15703311
[TBL] [Abstract][Full Text] [Related]
9. Dysembryoplastic neuroepithelial tumors: proton MR spectroscopy, diffusion and perfusion characteristics.
Bulakbasi N; Kocaoglu M; Sanal TH; Tayfun C
Neuroradiology; 2007 Oct; 49(10):805-12. PubMed ID: 17632714
[TBL] [Abstract][Full Text] [Related]
10. Rasmussen's encephalitis: proton MR spectroscopy and diffusion MR findings.
Sener RN
J Neuroradiol; 2000 Sep; 27(3):179-84. PubMed ID: 11104965
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in a patient with Pelizaeus-Merzbacher disease determined by repeated 1H-magnetic resonance spectroscopy.
Mori T; Mori K; Ito H; Goji A; Miyazaki M; Harada M; Kurosawa K; Kagami S
J Child Neurol; 2014 Feb; 29(2):283-8. PubMed ID: 24056155
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
[TBL] [Abstract][Full Text] [Related]
14. Longstanding tectal tumors: proton MR spectroscopy and diffusion MRI findings.
Sener RN
Comput Med Imaging Graph; 2002; 26(1):25-31. PubMed ID: 11734371
[TBL] [Abstract][Full Text] [Related]
15. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
[TBL] [Abstract][Full Text] [Related]
16. Combined MR measurements of magnetization transfer, tissue diffusion and proton spectroscopy. A feasibility study with neurological cases.
Back T; Möckel R; Hirsch JG; Gaa J; Oertel WH; Hennerici MG; Gass A
Neurol Res; 2003 Apr; 25(3):292-300. PubMed ID: 12739241
[TBL] [Abstract][Full Text] [Related]
17. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases.
Engelbrecht V; Scherer A; Rassek M; Witsack HJ; Mödder U
Radiology; 2002 Feb; 222(2):410-8. PubMed ID: 11818607
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
20. Lowe syndrome: proton mr spectroscopy, and diffusion mr imaging.
Sener RN
J Neuroradiol; 2004 Jun; 31(3):238-40. PubMed ID: 15356453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
